Search research articles
Contact Us
Filters
Showing results (31-40 of 87) with videos related to
Page
of 9
Sort By:
The Journal of Dermatological Treatment
|
April 26, 2021
Impact of PASI response on work productivity and the effect of risankizumab on indirect costs using machine learning in patients with moderate-to-severe psoriasis
Mark Lebwohl, Ahmed M Soliman, Hongbo Yang, et al.
Clinical Therapeutics
|
July 20, 2015
Relative Bioavailability of Apixaban Solution or Crushed Tablet Formulations Administered by Mouth or Nasogastric Tube in Healthy Subjects
Yan Song, Xiaoli Wang, Itay Perlstein, et al.
Expert Opinion on Pharmacotherapy
|
May 23, 2023
Indirect treatment comparison (ITC) of the efficacy of vutrisiran and tafamidis for hereditary transthyretin-mediated amyloidosis with polyneuropathy
Madeline Merkel, David Danese, Chongshu Chen, et al.
Clinical Pharmacology : Advances and Applications
|
December 20, 2013
Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects
Yimin Cui, Yan Song, Jessie Wang, et al.
Investigative Ophthalmology & Visual Science
|
December 28, 2023
Associations Between Autoimmune Disease and the Development of Age-Related Macular Degeneration
John Moir, Max J Hyman, Jessie Wang, et al.
Bioanalysis
|
November 30, 2023
Signal-to-noise ratio to assess magnitude, kinetics and impact on pharmacokinetics of the immune response to an adalimumab biosimilar
Davide Guerrieri, Matej Horvat, Jamie Fan, et al.
Plos One
|
July 21, 2023
Accelerated high-throughput imaging and phenotyping system for small organisms
Talha Kose, Tiago F Lins, Jessie Wang, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
November 27, 2013
Effect of activated charcoal on apixaban pharmacokinetics in healthy subjects
Xiaoli Wang, Sabiha Mondal, Jessie Wang, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
April 15, 2014
Safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple doses of apixaban in healthy Japanese male subjects
Naomi Yamahira, Charles Frost, Hiroyuki Fukase, et al.
Translational Vision Science & Technology
|
August 1, 2022
Changes in Rat Scleral Collagen Structure Induced by UVA-Riboflavin Crosslinking at Various Tissue Depths in Whole Globe Versus Scleral Patch
Yuan Miao, Juan Liu, Sruti S Akella, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 87) with videos related to
Sort By:
Page
of 9
The Journal of Dermatological Treatment
|
April 26, 2021
Impact of PASI response on work productivity and the effect of risankizumab on indirect costs using machine learning in patients with moderate-to-severe psoriasis
Mark Lebwohl, Ahmed M Soliman, Hongbo Yang, et al.
Clinical Therapeutics
|
July 20, 2015
Relative Bioavailability of Apixaban Solution or Crushed Tablet Formulations Administered by Mouth or Nasogastric Tube in Healthy Subjects
Yan Song, Xiaoli Wang, Itay Perlstein, et al.
Expert Opinion on Pharmacotherapy
|
May 23, 2023
Indirect treatment comparison (ITC) of the efficacy of vutrisiran and tafamidis for hereditary transthyretin-mediated amyloidosis with polyneuropathy
Madeline Merkel, David Danese, Chongshu Chen, et al.
Clinical Pharmacology : Advances and Applications
|
December 20, 2013
Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects
Yimin Cui, Yan Song, Jessie Wang, et al.
Investigative Ophthalmology & Visual Science
|
December 28, 2023
Associations Between Autoimmune Disease and the Development of Age-Related Macular Degeneration
John Moir, Max J Hyman, Jessie Wang, et al.
Bioanalysis
|
November 30, 2023
Signal-to-noise ratio to assess magnitude, kinetics and impact on pharmacokinetics of the immune response to an adalimumab biosimilar
Davide Guerrieri, Matej Horvat, Jamie Fan, et al.
Plos One
|
July 21, 2023
Accelerated high-throughput imaging and phenotyping system for small organisms
Talha Kose, Tiago F Lins, Jessie Wang, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
November 27, 2013
Effect of activated charcoal on apixaban pharmacokinetics in healthy subjects
Xiaoli Wang, Sabiha Mondal, Jessie Wang, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
April 15, 2014
Safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple doses of apixaban in healthy Japanese male subjects
Naomi Yamahira, Charles Frost, Hiroyuki Fukase, et al.
Translational Vision Science & Technology
|
August 1, 2022
Changes in Rat Scleral Collagen Structure Induced by UVA-Riboflavin Crosslinking at Various Tissue Depths in Whole Globe Versus Scleral Patch
Yuan Miao, Juan Liu, Sruti S Akella, et al.
Page
of 9